Clinical Trial to Study the Effects of Dietary Flax Beverage on Memory and Cognition

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

September 21, 2023

Study Completion Date

December 19, 2023

Conditions
Memory; Disturbance, Mild
Interventions
DIETARY_SUPPLEMENT

flaxseed beverage

"Pizzey Ingredients Inc. introduced a flax beverage product that is a plant-based beverage product that is designed as an alternative to non-diary milks (almond milk \& soy milk). Each 330 ml serving of flax beverage contains 15 g flaxseed, which amounts to 3.75 gm of omega-3 fatty acid. Preventing MCI or even AD may be within reach, if appropriate measures are taken early enough using strategies such as dietary supplementation."

DIETARY_SUPPLEMENT

control beverage

Oat fibre control. For 180 days (6 months) participants will consume 2 servings of 330 ml of placebo beverage (i.e. normal fiber beverage; control) per day.

Trial Locations (2)

R2H 2A6

I.H. Asper Clinical Research Institute, Winnipeg

R3A 1R9

Health Sciences Ctr., Winnipeg

All Listed Sponsors
collaborator

Pizzey Ingredients

UNKNOWN

collaborator

Canadian Agricultural Partnership

UNKNOWN

lead

St. Boniface Hospital

OTHER

NCT04645927 - Clinical Trial to Study the Effects of Dietary Flax Beverage on Memory and Cognition | Biotech Hunter | Biotech Hunter